(Q40816880)

24 September 2017

Calmodulin enhances the stability of the estrogen receptor (English)

1 reference

24 September 2017

3

1 reference

24 September 2017

Li Z

1

1 reference

24 September 2017

Joyal JL

series ordinal

2

1 reference

24 September 2017

language of work or name

English

0 references

publication date

15 February 2001

1 reference

Journal of Biological Chemistry

24 September 2017

1 reference

24 September 2017

276

1 reference

24 September 2017

17354-17360

1 reference

24 September 2017

20

1 reference

Calmodulin-specific monoclonal antibodies inhibit DNA replication in mammalian cells

24 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M010238200

Immunocytochemical localization of calmodulin in PC12 cells and its possible interaction with histones

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M010238200

A study on the levels of calmodulin and DNA in human lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M010238200

The effect of trifluoperazine, a calmodulin antagonist, on the growth of normal and malignant epidermal keratinocytes in culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M010238200

Mechanisms of tamoxifen resistance in the treatment of advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M010238200

Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M010238200

Calmodulin-stimulated phosphorylation of 17 beta-estradiol receptor on tyrosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M010238200

Calmodulin is essential for estrogen receptor interaction with its motif and activation of responsive promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M010238200

Monoclonal antibody to calmodulin: development, characterization, and comparison with polyclonal anti-calmodulin antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M010238200

Production of high-titer helper-free retroviruses by transient transfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M010238200

Functional elimination of calmodulin within the nucleus by targeted expression of an inhibitor peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M010238200

Calmodulin modulates the interaction between IQGAP1 and Cdc42. Identification of IQGAP1 by nanoelectrospray tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M010238200

Selective estrogen receptor modulators (SERMs): A first step in the development of perfect hormone replacement therapy regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M010238200

The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M010238200

Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M010238200

Calmodulin binds to p21(Cip1) and is involved in the regulation of its nuclear localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M010238200

Calmodulin levels in oestrogen receptor positive and negative human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M010238200

Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M010238200

Molecular mechanisms of action of steroid/thyroid receptor superfamily members

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M010238200

Reconstitution of an endothelial nitric-oxide synthase (eNOS), hsp90, and caveolin-1 complex in vitro. Evidence that hsp90 facilitates calmodulin stimulated displacement of eNOS from caveolin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M010238200

Breast cancer: cause and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M010238200

Synergistic induction of apoptosis in breast cancer cells by tamoxifen and calmodulin inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M010238200

Response of estrogen receptor containing tumour cells to pure antiestrogens and the calmodulin inhibitor, calmidzolium chloride.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M010238200

Selective Interaction of hsp90 with an Estrogen Receptor Ligand-binding Domain Containing a Point Mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M010238200

Estradiol derivatives bearing the side-chain of tamoxifen antagonize the association between the estrogen receptor and calmodulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M010238200

Modulation of estradiol and DNA binding to estrogen receptor upon association with calmodulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M010238200

Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M010238200

Rationally designed analogues of tamoxifen with improved calmodulin antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M010238200

Binding of IRS proteins to calmodulin is enhanced in insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M010238200

Inhibition of human breast cancer colony formation by anticalmodulin agents: trifluoperazine, W-7, and W-13

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M010238200

21 January 2018

Identifiers

DOI

10.1074/JBC.M010238200

1 reference

release_zv42pfba3fgbxhagvbavtommhu

24 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zv42pfba3fgbxhagvbavtommhu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference